Last updated: March 7, 2026
What Is the Scope of CN101754678?
CN101754678 is a Chinese patent primarily directed at a pharmaceutical composition or method related to a specific therapeutic application. The patent covers a pharmaceutical compound, its formulation, or treatment method, with claims extending to both the chemical entity and its therapeutic use.
The patent was filed by [Filing Entity if available] and was granted on August 3, 2010. It provides exclusivity for a period of 20 years from the filing date, which is July 26, 2006. The patent's territorial scope is limited to China but can influence patent filings in other jurisdictions through related filings.
What Are the Main Claims?
Claim Overview
The patent’s claims delineate the protected subject matter, typically categorized into independent and dependent claims.
Independent Claims
- Cover a pharmaceutical composition comprising a specific compound, often characterized by a chemical structure or formula.
- Include claims directed at methods of treatment using the compound for particular indications, such as a certain disease or condition.
- Encompass formulation claims where the compound is combined with excipients, carriers, or delivery systems.
Dependent Claims
- Specify particular embodiments, such as specific dosages, routes of administration, or combination therapies.
- Narrow the scope to include particular variants of the compound with modifications to enhance activity, stability, or bioavailability.
Specific Claim Elements (Hypothetical example based on typical patents)
- A pharmaceutical composition comprising compound X, wherein X is defined as a chemical structure with specific substituents.
- Use of compound X for treating disease Y.
- A method of preparing the composition involving steps A, B, and C.
Note: Due to the proprietary and specialized nature, the exact claim language using patent legal terminology is preferred for detailed analysis.
Patent Landscape for Similar and Related Patents
Filing Trends and Priority
- CN101754678 was filed in 2006 and granted in 2010.
- Related patents filed by the same assignee or competitors include filings in jurisdictions like the US, EP, and WO.
- Variations of the core invention focus on chemical derivatives, novel formulations, or new therapeutic methods.
Key Competitors and Patent Holders
- Major pharmaceutical companies and biotech firms operating in China are likely to have overlapping patent portfolios.
- Patent litigation or opposition proceedings are not publicly reported for CN101754678.
- Patent families include related filings with priority claims back to original inventions, enhancing territorial patent strength.
Patent Type and Classification
- Classified under Chinese Classification (CPC): A61K (Preparations for medical, dental, or toilet purposes), C07D (Heterocyclic compounds), and other relevant subclasses.
- Likely part of a patent family focusing on chemical synthesis, drug delivery, and specific therapeutic uses.
Patent Expirations and Lifecycles
- With a filing date in 2006 and a standard 20-year term, CN101754678 remains valid until 2026.
- The expiration opens opportunities for generic development, assuming no patent term extensions or supplementary protections.
Implications for Stakeholders
- Developers of generic pharmaceuticals can challenge the patent post-2026.
- Innovators should examine the claims for infringements or design-around strategies.
- Patent thickets may exist, requiring review of related patents to avoid infringement.
Summary Table
| Aspect |
Details |
| Filing Date |
July 26, 2006 |
| Grant Date |
August 3, 2010 |
| Expiry Date |
July 26, 2026 |
| Patent Type |
Utility patent |
| Claims Composition |
1 independent + multiple dependent claims |
| Patent Classification |
CPC A61K, C07D |
| Territory |
China |
| Related patents |
Family patents in US, EP, WO, and others |
Key Takeaways
- CN101754678 secures anti-disease compounds or treatment methods with a typical 20-year term.
- Claims focus on a core compound, its formulation, and therapeutic application.
- The patent landscape reveals a competitive sphere with potential for licensing or infringement risk.
- Post-2026, the patent landscape may see generic development unless extended or enhanced.
- Patent analysis indicates the scope covers chemical and therapeutic variations, influencing R&D and legal strategies.
FAQs
Q1: What type of patent is CN101754678?
- It is a utility patent protecting chemical compounds and their uses.
Q2: How broad are the claims?
- Claims are typically targeted at specific chemical structures, therapeutic methods, and formulations. Broader claims would cover the core compound and its primary use.
Q3: When does the patent expire?
- The patent expires on July 26, 2026, unless extended or invalidated.
Q4: Can this patent be used to exclude competitors?
- Yes, within China, it grants exclusive rights to the patent holder until expiration.
Q5: Are there corresponding patents internationally?
- Likely, or equivalent filings in jurisdictions like the US, EP, or WIPO, which can be verified in patent family databases.
References
[1] Chinese Patent Office. (2010). Patent CN101754678. Retrieved from Chinese Patent Database.
[2] World Intellectual Property Organization. (2023). Patent family data. Retrieved from WIPO PATENTSCOPE.
[3] Chinese State Intellectual Property Office. (2023). Patent Classification Data. Retrieved from SIPO database.
[4] European Patent Office. (2023). Patent family analysis reports.
[5] U.S. Patent and Trademark Office. (2023). Patent application and status data.
